Cellebrite DI Ltd. (CLBT)

Cellebrite DI Ltd. (CLBT $11.86)
- $11.86 Cap: $2.94B
- View CLBT Profile
- View Questions on CLBT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Axon Enterprise Inc. (AXON $380.86)
- $380.86 P/E (TTM): 238.17X Cap: $30.62B
- View AXON Profile
- View Questions on AXON
Cellebrite DI Ltd. (CLBT $11.86)
- $11.86 Cap: $2.94B
- View CLBT Profile
- View Questions on CLBT

Q: These 2 stocks have been really beat up lately it seems because of the higher valuations vs results and AI fears.

But if you listen to the most recent earnings calls AI is actually a driving force behind their results, their ability to drive efficiencies / scale and is exactly the kind of 'benefit' that AI can provide (eg. combing through large amounts of data - many of which most humans don't even want to see, writing reports and synthesizing interactions etc) And they operate in industries where switching costs are huge and the barriers to entry and data privacy issues / cybersecurity is paramont.

I really think the market is wrong on these names - when do you think the shareholders will be rewarded? I realise long term that AXON has well out performed but over the past year or so it is below standards.

Read Answer Asked by Michael on April 12, 2026

Commvault Systems Inc. (CVLT $89.61)
- $89.61 P/E (TTM): 46.44X Cap: $3.94B
- View CVLT Profile
- View Questions on CVLT
Genius Sports Limited (GENI $4.27)
- $4.27 Cap: $1.09B
- View GENI Profile
- View Questions on GENI
Cellebrite DI Ltd. (CLBT $11.86)
- $11.86 Cap: $2.94B
- View CLBT Profile
- View Questions on CLBT

Q: Hello,

1)Have the fundamentals and future prospects for these companies improved or declined in the past 12 mos?

2)Does any look interesting at current levels?

Love the service and always look forward to reading your insights.

Read Answer Asked by Trevor on April 10, 2026

The Boeing Company (BA $223.77)
- $223.77 P/E (TTM): 87.75X Cap: $174.56B
- View BA Profile
- View Questions on BA
Eli Lilly and Company (LLY $922.50)
- $922.50 P/E (TTM): 40.94X Cap: $871.59B
- View LLY Profile
- View Questions on LLY
Synchrony Financial (SYF $75.55)
- $75.55 P/E (TTM): 7.77X Cap: $25.01B
- View SYF Profile
- View Questions on SYF
Zoetis Inc. Class A (ZTS $121.11)
- $121.11 P/E (TTM): 19.58X Cap: $50.94B
- View ZTS Profile
- View Questions on ZTS
Constellation Software Inc. (CSU $2,515.75)
- $2,515.75 P/E (TTM): 72.86X Cap: $53.31B
- View CSU Profile
- View Questions on CSU
- View Reports on CSU
Tesla Inc. (TSLA $364.20)
- $364.20 P/E (TTM): 323.1X Cap: $1.36T
- View TSLA Profile
- View Questions on TSLA
Blackstone Inc. (BX $126.33)
- $126.33 P/E (TTM): 29.6X Cap: $93.75B
- View BX Profile
- View Questions on BX
Brookfield Business Partners L.P. (BBU.UN $44.00)
- $44.00 Cap: $9.25B
- View BBU.UN Profile
- View Questions on BBU.UN
NewMarket Corp (NEU $654.29)
- $654.29 P/E (TTM): 14.14X Cap: $5.90B
- View NEU Profile
- View Questions on NEU
Cellebrite DI Ltd. (CLBT $11.86)
- $11.86 Cap: $2.94B
- View CLBT Profile
- View Questions on CLBT
Brookfield Asset Management Ltd. Class A Limited Voting Shares (BAM $65.39)
- $65.39 P/E (TTM): 30.45X Cap: $107.12B
- View BAM Profile
- View Questions on BAM

Q: Keep or Sale
US, BX,BA,CLBT,RSPH,LLY,NEU,SYF,TSLA,ZTS
cdn. bbu.un,Bam.csu.

Read Answer Asked by Nizar on April 08, 2026